Earlam R, Cunha-Melo J R
Br J Surg. 1980 Jun;67(6):381-90. doi: 10.1002/bjs.1800670602.
Authors writing an oesophageal cancer include adenocarcinoma to a variable extent--between 1 and 75 per cent--but the true incidence of this histological type is about 1 per cent. Most adenocarcinomas are gastric in origin, involving the lower oesophagus, have a lower operative mortality than in the middle or upper one-third of the oesophagus and poorer prognosis than squamous cell carcinoma, but there is no alternative treatment to surgery. Squamous cell carcinoma of the oesophagus, separated incompletely but as far as possible, has been analysed by reviewing data on 83 783 patients in 122 paERS. After trying to standardize the data, it appears that of 100 patients with the condition, 58 will be explored and 39 have the tumour resected, of whom 13 will die in hospital. Of the 26 patients leaving hospital with the tumour excised, 18 will survive for 1 year, 9 for 2 years and 4 for 5 years. Oesophageal resection for squamous cell carcinoma has the highest operative mortality of any routinely performed surgical procedure today.
撰写关于食管癌的作者在不同程度上纳入了腺癌——比例在1%至75%之间——但这种组织学类型的实际发病率约为1%。大多数腺癌起源于胃,累及食管下段,手术死亡率低于食管中、上三分之一段,且预后比鳞状细胞癌差,但除手术外没有其他替代治疗方法。对122项研究中83783例患者的数据进行回顾分析后,对食管鳞状细胞癌(尽可能不完全分离)进行了分析。在试图使数据标准化后,似乎每100例患有这种疾病的患者中,58例将接受探查,39例切除肿瘤,其中13例将在医院死亡。在26例肿瘤切除后出院的患者中,18例将存活1年,9例存活2年,4例存活5年。食管鳞状细胞癌切除术是目前常规进行的任何外科手术中手术死亡率最高的。